# Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder

> **NCT06955845** · NA · COMPLETED · sponsor: **Asad Ullah Jan** · enrollment: 60 (actual)

## Conditions studied

- PTSD
- PTSD - Post Traumatic Stress Disorder

## Interventions

- **BEHAVIORAL:** Eye Movement Desensitization and Reprocessing Therapy
- **DRUG:** Selective serotonin reuptake inhibitors

## Key facts

- **NCT ID:** NCT06955845
- **Lead sponsor:** Asad Ullah Jan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-06
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955845, "Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06955845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
